CSL Behring
-
CSL to Invest $1.5B in U.S. Growth Amid Restructuring and Local Layoffs
CSL, which has major operations in King of Prussia, announced plans to expand in the U.S., reports John George for the Philadelphia Business Journal. The…
-
Parent Company of King of Prussia-Based CSL Behring to Eliminate 3,000 Jobs Globally
CSL, the Australian biotechnology company behind CSL Behring in King of Prussia, plans to cut up to 15 percent of its global workforce, or about…
-
Boathouse Row to Light Up for Rare Disease Day, Says King of Prussia’s CSL Behring CEO
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul Perreault said in a video…
-
CSL Behring Partners with Uplifting Athletes for Rare Disease Research and Honors Those Making an Impact
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising young investigative rare disease researchers…
Founding Partners
Advertisement
Affiliate Partners
